Tracking antibiotic resistance in pneumonia patients
Part of Infections, Lungs & breathing clinical trials.
This study uses advanced genetic testing to monitor antibiotic-resistant bacteria in people with pneumonia. It aims to understand how resistance develops and improve treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with severe or mild pneumonia based on standard guidelines.
- You are an adult or child meeting the specific pneumonia severity criteria.
- You have a leftover sample from a standard test, like a nose swab, throat swab, sputum, blood, or lung fluid.
- Your sample is not contaminated, and if you had lung fluid drawn, there was enough (at least 200 microliters).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with HIV/AIDS who develop severe pneumonia or septic shock. It uses a special genetic test (metagenomic next-generation sequencing) to find the exact germ causing the infection so doctors can choose the right antibiotic.
This study looks at medical records from adults who have pneumonia with a confirmed germ, to better understand how the disease develops and how people recover. It may help guide future care decisions.
This study uses a powerful genetic test (next-generation sequencing) to find the cause of respiratory infections when standard tests fail. It may help identify hard-to-detect viruses, bacteria, or fungi in your lung or airway samples.
This study looks at how bacteria in your body (microbiome) affect how sick you get from severe pneumonia. It may help doctors find better ways to treat people with serious lung infections who need breathing support.
This trial studies whether a more detailed genetic test of lung fluids can find the exact cause of pneumonia in people whose first treatment isn't working, and help doctors choose a more effective treatment sooner.
This trial looks at whether a special genetic test (tNGS) can predict which antibiotics will work for bacteria causing lung infections. It may help doctors choose the right treatment faster.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.